636 related articles for article (PubMed ID: 12606497)
1. Selective glycogen synthase kinase 3 inhibitors potentiate insulin activation of glucose transport and utilization in vitro and in vivo.
Ring DB; Johnson KW; Henriksen EJ; Nuss JM; Goff D; Kinnick TR; Ma ST; Reeder JW; Samuels I; Slabiak T; Wagman AS; Hammond ME; Harrison SD
Diabetes; 2003 Mar; 52(3):588-95. PubMed ID: 12606497
[TBL] [Abstract][Full Text] [Related]
2. Modulation of muscle insulin resistance by selective inhibition of GSK-3 in Zucker diabetic fatty rats.
Henriksen EJ; Kinnick TR; Teachey MK; O'Keefe MP; Ring D; Johnson KW; Harrison SD
Am J Physiol Endocrinol Metab; 2003 May; 284(5):E892-900. PubMed ID: 12517738
[TBL] [Abstract][Full Text] [Related]
3. Short-term in vitro inhibition of glycogen synthase kinase 3 potentiates insulin signaling in type I skeletal muscle of Zucker Diabetic Fatty rats.
Henriksen EJ; Teachey MK
Metabolism; 2007 Jul; 56(7):931-8. PubMed ID: 17570255
[TBL] [Abstract][Full Text] [Related]
4. Effects of a novel glycogen synthase kinase-3 inhibitor on insulin-stimulated glucose metabolism in Zucker diabetic fatty (fa/fa) rats.
Cline GW; Johnson K; Regittnig W; Perret P; Tozzo E; Xiao L; Damico C; Shulman GI
Diabetes; 2002 Oct; 51(10):2903-10. PubMed ID: 12351425
[TBL] [Abstract][Full Text] [Related]
5. Oxidative stress-induced insulin resistance in rat skeletal muscle: role of glycogen synthase kinase-3.
Dokken BB; Saengsirisuwan V; Kim JS; Teachey MK; Henriksen EJ
Am J Physiol Endocrinol Metab; 2008 Mar; 294(3):E615-21. PubMed ID: 18089761
[TBL] [Abstract][Full Text] [Related]
6. Acute selective glycogen synthase kinase-3 inhibition enhances insulin signaling in prediabetic insulin-resistant rat skeletal muscle.
Dokken BB; Sloniger JA; Henriksen EJ
Am J Physiol Endocrinol Metab; 2005 Jun; 288(6):E1188-94. PubMed ID: 15671078
[TBL] [Abstract][Full Text] [Related]
7. Glucocorticoid-induced insulin resistance in skeletal muscles: defects in insulin signalling and the effects of a selective glycogen synthase kinase-3 inhibitor.
Ruzzin J; Wagman AS; Jensen J
Diabetologia; 2005 Oct; 48(10):2119-30. PubMed ID: 16078016
[TBL] [Abstract][Full Text] [Related]
8. Chronic selective glycogen synthase kinase-3 inhibition enhances glucose disposal and muscle insulin action in prediabetic obese Zucker rats.
Dokken BB; Henriksen EJ
Am J Physiol Endocrinol Metab; 2006 Aug; 291(2):E207-13. PubMed ID: 16478771
[TBL] [Abstract][Full Text] [Related]
9. Essential role of p38 MAPK for activation of skeletal muscle glucose transport by lithium.
Harrell NB; Teachey MK; Gifford NJ; Henriksen EJ
Arch Physiol Biochem; 2007; 113(4-5):221-7. PubMed ID: 18158645
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of glycogen synthase kinase 3 improves insulin action and glucose metabolism in human skeletal muscle.
Nikoulina SE; Ciaraldi TP; Mudaliar S; Carter L; Johnson K; Henry RR
Diabetes; 2002 Jul; 51(7):2190-8. PubMed ID: 12086949
[TBL] [Abstract][Full Text] [Related]
11. Metabolism and insulin signaling in common metabolic disorders and inherited insulin resistance.
Højlund K
Dan Med J; 2014 Jul; 61(7):B4890. PubMed ID: 25123125
[TBL] [Abstract][Full Text] [Related]
12. Potential role of glycogen synthase kinase-3 in skeletal muscle insulin resistance of type 2 diabetes.
Nikoulina SE; Ciaraldi TP; Mudaliar S; Mohideen P; Carter L; Henry RR
Diabetes; 2000 Feb; 49(2):263-71. PubMed ID: 10868943
[TBL] [Abstract][Full Text] [Related]
13. Cocoa-rich diet ameliorates hepatic insulin resistance by modulating insulin signaling and glucose homeostasis in Zucker diabetic fatty rats.
Cordero-Herrera I; Martín MÁ; Escrivá F; Álvarez C; Goya L; Ramos S
J Nutr Biochem; 2015 Jul; 26(7):704-12. PubMed ID: 25814291
[TBL] [Abstract][Full Text] [Related]
14. Roles of insulin signalling and p38 MAPK in the activation by lithium of glucose transport in insulin-resistant rat skeletal muscle.
Macko AR; Beneze AN; Teachey MK; Henriksen EJ
Arch Physiol Biochem; 2008 Dec; 114(5):331-9. PubMed ID: 19023684
[TBL] [Abstract][Full Text] [Related]
15. Use of lithium and SB-415286 to explore the role of glycogen synthase kinase-3 in the regulation of glucose transport and glycogen synthase.
MacAulay K; Hajduch E; Blair AS; Coghlan MP; Smith SA; Hundal HS
Eur J Biochem; 2003 Sep; 270(18):3829-38. PubMed ID: 12950267
[TBL] [Abstract][Full Text] [Related]
16. More marked stimulation by lithium than insulin of the glycogenic pathway in rat skeletal muscle.
Fürnsinn C; Noe C; Herdlicka R; Roden M; Nowotny P; Leighton B; Waldhäusl W
Am J Physiol; 1997 Sep; 273(3 Pt 1):E514-20. PubMed ID: 9316440
[TBL] [Abstract][Full Text] [Related]
17. Role of glycogen synthase kinase-3 in insulin resistance and type 2 diabetes.
Henriksen EJ; Dokken BB
Curr Drug Targets; 2006 Nov; 7(11):1435-41. PubMed ID: 17100583
[TBL] [Abstract][Full Text] [Related]
18. Dysregulation of glycogen synthase kinase-3 in skeletal muscle and the etiology of insulin resistance and type 2 diabetes.
Henriksen EJ
Curr Diabetes Rev; 2010 Sep; 6(5):285-93. PubMed ID: 20594161
[TBL] [Abstract][Full Text] [Related]
19. Tissue-specific role of glycogen synthase kinase 3beta in glucose homeostasis and insulin action.
Patel S; Doble BW; MacAulay K; Sinclair EM; Drucker DJ; Woodgett JR
Mol Cell Biol; 2008 Oct; 28(20):6314-28. PubMed ID: 18694957
[TBL] [Abstract][Full Text] [Related]
20. Development of glucose intolerance in male transgenic mice overexpressing human glycogen synthase kinase-3beta on a muscle-specific promoter.
Pearce NJ; Arch JR; Clapham JC; Coghlan MP; Corcoran SL; Lister CA; Llano A; Moore GB; Murphy GJ; Smith SA; Taylor CM; Yates JW; Morrison AD; Harper AJ; Roxbee-Cox L; Abuin A; Wargent E; Holder JC
Metabolism; 2004 Oct; 53(10):1322-30. PubMed ID: 15375789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
